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Abstract
Introduction: The aim of study is comparing the haemostatic properties of
conventional monopolar resection (TURP) and bipolar transurethral resection in
saline (TURIS) of the prostate in patients under chronic oral anticoagulants.
Material and methods: Out of a cohort group of 550 endoscopic resections for
bladder outlet obstruction, 176 patients on chronic oral anticoagulant therapy
required endoscopic resection either by monopolar TURP or bipolar TURIS
technology. Changes in haemoglobin, blood transfusion, and clot retention were
compared between both groups.
Results: Mean postoperative change in haemoglobin level was –1.21 ±0.92 mg/dl in
the TURP group compared to –1.29 ±0.99 mg/dl in the TURIS group (p = 0.603). The
need for blood transfusions and the mean numbers of units transfused did not
significantly differ between the 2 groups. Clot retention appeared in 12 patients (15%)
in the TURP group compared to 13 patients (13%) in the TURIS group (p = 0.828). 
Conclusions: Despite promising experimental results of better haemostasis and
deeper coagulation depth, bipolar technology does not permit one to reduce
the amount of blood loss when compared to patients treated by conventional
monopolar technology in this study group of patients on oral anticoagulation
therapy. Patients on oral anticoagulants suffer more incidents of clot retention,
which sometimes results in re-hospitalisation.
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Introduction
Conventional monopolar transurethral resection of the prostate is still
the gold standard in the surgical treatment of benign prostatic hyperplasia
[1]. Bipolar transurethral resection is advocated to claim this position [2].
This new technology permits one to obtain identical postoperative success
rates and a lower peri- and postoperative complication rate. Autorino et
al. highlighted the outcome regarding International Prostate Symptom
Score (IPSS), QOL, flow rate and post-voiding residual after 4 years [3].
Furthermore, with the use of saline 0.9% instead of glycine the dreaded
TUR syndrome can be avoided. A meta-analysis of all randomized controlled
studies by Mamoulakis et al. showed that there was not a single TUR
syndrome in the bipolar group [4].
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Recent experimental laboratory investigations
showed a lower bleeding rate and deeper
coagulation capacity with the bipolar armamen  -
tarium [5, 6]. This could lead to lower blood loss,
fewer transfusions and a reduced risk of clot
retention in the clinical setting. Randomised
controlled clinical trials were completed to compare
these parameters both with conventional mo  -
nopolar and bipolar technology [4]. Of particular
interest for this are patients under anticoagulation
therapy, either antivitamins K or antiplatelets. Most
of the time these therapeutic medications need to
be continued, although they are not the surgeon's
best friend. Therefore, we analysed this in patients
under oral anticoagulants to see whether bipolar
technology has an additional value for them.
Material and methods
Between April 2005 and February 2009, 
176 patients on chronic oral anticoagulant therapy
who required endoscopic transurethral resection of
the prostate for bladder outlet obstruction were
treated either by conventional monopolar or bipolar
surgery. The minimal inclusion criteria for entry
were an International Prostate Symptom Score of
13 or more, QOL index of 3 or more, and maximal
urinary flow rates below 15 ml per second. Exclusion
criteria were neurogenic bladder, prostate cancer,
previous prostatic or urethral surgery, and bladder
stones.
A standard protocol was used regarding the
replacement of oral coagulants with preoperative
injections of low molecular weight heparins (LMWH)
and the restart of oral anticoagulants in the early
postoperative phase. Patients on antivitamin K
stopped the intake of oral medication 5 days before
surgery. The LMWH were started at a therapeutic
dose. One day postoperatively, antivitamins were
restarted. Patients on antiplatelets stopped the
intake 7 days before surgery, had subcutaneous
LMWH injections at therapeutic doses for 1 week
and restarted their antiplatelets the day after
resection. Patients with coronary stents on
clopidogrel continued this medication.
The indications for chronic oral anticoagulant
therapy are presented in Table I. Antivitamins were
taken for atrial fibrillation, prosthetic heart valve
and a history of deep venous thrombosis or
pulmonary embolism. Aspirin was prescribed as
a single treatment strategy after myocardial
infarction or in combination with clopidogrel after
coronary stenting. 
All endoscopic resections were performed by two
staff urologists (DM, JB). Both were familiar with
the monopolar and bipolar equipment. A standard
Olympus resectoscope (24 Fr) and an Olympus UES-
40 SurgMaster electrical current generator were
used for both techniques. Monopolar TURP was
done with standard loops using 175 W cutting
power and 75 W coagulation power. Bipolar TURIS
was performed using a bipolar electrode set at
270W for cutting and 75 W for coagulation. All
procedures were performed with intermittent
glycine 1.5% or saline 0.9% irrigation using general
or spinal anaesthesia. A full blood count was
determined 24 h after surgery.
Parameters of interest in the perioperative
management were changes in haemoglobin, blood
transfusion needed, duration of indwelling catheter
placement and bladder irrigation, episodes of clot
retention and duration of hospital stay.
All statistical tests performed were 2-sided and
at the 5% level of significance (type I error). The 
2 groups were compared using the independent 
t-test. Because of the large sample size the data
were not required to have a normal distribution.
Complications as TUR syndrome, clot retention,
need for transfusion and urinary retention were
assessed by Fisher’s exact test. The p-values obtai  -
ned were similar to the χ2 test with conti  nuity
correction. SPSS version 17.0 was used to perform
the tests.
Results
Of 550 men with bladder outlet obstruction
treated by transurethral endoscopic resection, 
176 patients were under chronic anticoagulant
therapy, i.e. antivitamins K in 92 patients, and
antiplatelet therapy in 84 patients. 
The conventional transurethral resection group
included 78 patients (42 on antivitamins K and 36
on antiplatelets), while 98 patients were operated
on using the bipolar TURIS technique (51 on
antivitamins K and 47 on antiplatelets).
Mean postoperative drop in haemoglobin was
1.25 ±0.95 mg/dl in patients on chronic anti  -
coagulant therapy compared to a decline of 1.26
±1.17 mg/dl in all the other patients of the cohort
group (p = 0.950). No statistically significant
Variables Monopolar Bipolar
TURPT U RIS
N (%) N (%)
Antivitamins K 42 50
Atrial fibrillation 21 21
Prosthetic heart valve 2 1
Thromboembolic event 19 28
Antiplatelets 36 48
Coronary stenting 21 27
Prevention 15 21
Table I. Aetiology for anticoagulants
TURP – transurethral resection of prostate, TURIS – transurethral
resection in saline of prostate, N – number
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difference in haemoglobin drop was observed
between patients whether they were on
anticoagulants or not, both in the conventional
monopolar resection group (p = 0.750) and in the
bipolar TURIS group (p = 0.866).
Postoperative clot retention was observed in 
25 patients on anticoagulant therapy (14.2%) and
in 22 non-anticoagulated patients (5.9%) (p = 0.006).
In patients on oral anticoagulants, the operation
technology did not influence the outcome. Patient-
related and operation characteristics of both
resection groups are reported in Table II. In the
conventional monopolar resection group, 52 pa  -
tients (67%) were treated under spinal anaesthesia
and 26 (33%) under general anaesthesia. In the
bipolar group, the distribution was 76 (78%) and 22
(22%) respectively. Although volume measurements
of both the prostate and the adenoma were similar,
resection time and resection speed were statistically
significantly slower in the bipolar TURIS group 
(p < 0.000). 
Mean postoperative change in haemoglobin level
was –1.21 ±0.92 mg/dl in the TURP group compared
to –1.29 ±0.99 mg/dl in the TURIS group (p = 0.603).
Blood transfusions were required in 2 patients in
the TURP group compared to 1 in the TURIS group
(p = 0.585). No TUR syndromes were observed in
either group. 
Clot retention appeared in 12 patients (15%) in
the TURP group compared to 13 patients (13%) in
the TURIS group (p = 0.828). In the TURP group, 
6 clot incidents appeared immediately after catheter
removal and were successfully resolved. Six patients
with delayed bleeding needed to be re-hospitalized
1 or 2 weeks later. In the TURIS group, there were
8 early and five late incidents. All clot retention
incidents were managed conservatively by
reinsertion of an indwelling catheter, manual
removal of the blood clots and continuation of
bladder irrigation until gross haematuria resolved. 
Sub-analysis of each mean of anticoagulation
showed no significant difference between the two
technologies. Patients on oral antivitamins K had
a drop in haemoglobin of 0.92 ±0.83 mg/dl in the
monopolar group and 1.16 ±1.11 mg/dl in the bipolar
group (p = 0.266). For patients on antiplatelets this
was 1.55 ±0.92 mg/dl and 1.41 ±0.83 mg/dl,
respectively (p = 0.508). 
Discussion
The prostate has a rich blood supply. The
development of the adenoma is accompanied by
a significant increase of angiogenesis and formation
of aberrant blood vessels. This can cause substantial
intra-operative bleeding. The size of the vessels in
the prostatic adenoma is also of importance [7].
Huang  et al. studied the diameters of the
microvessels in 22 prostates [7]. The mean diameter
in hyperplasic prostates was 21.19 ±12.8 μm, but
0.1% of the vessels measured 125-140 μm [7]. The
coagulation depth should extend far enough to seal
these large blood vessels. 
Recent laboratory work was done to investigate
the haemostatic capacity of bipolar devices. Wendt-
Nordahl  et al. examined the blood loss in
a modified model of the isolated blood-perfused
porcine kidney model [5]. They observed lower
bleeding rates (15.16 ±3.31 g/min) with the bipolar
device than with the monopolar device (20.78 ±1.52
g/min) [5]. Experimental work by Huang et al.
reported that the coagulation zones are statistically
significantly deeper with a bipolar device (237.73
±20.12 μm) than with monopolar devices (200.75
±19.34 μm) in canine prostates [6]. It also appeared
that the few larger blood vessels are sealed by
bipolar technology. Furthermore, Wendt-Nordahl
et al. showed that bipolar cutting ended in
a marginally deeper coagulation zone (236.25
±36.69 μm) compared with the extent of the
Variables Monopolar TURP  Bipolar TURIS  Value of p 95% confidence 
Mean (± SD) Mean (± SD) interval of the difference
Age [year] 73.64 (±8.76) 75.11 (±7.83) 0.242 (–3.943, 1.001)
Prostate [ml] 55.61 (±24.01) 55.11 (±16.29) 0.902 (–7.575, 8.584)
Adenoma [ml] 32.72 (±15.04) 34.68 (±10.67) 0.447 (–7.065, 3.139)
PSA [ng/ml] 5.35 (±5.41) 9.05 (±16.72) 0.148 (–8.745, 1.340)
Operative time [min] 37 (±19) 57 (±22) 0.000 (–26.31, –13.69)
Resection weight [g] 20.21 (±11.88) 19.44 (±11.53) 0.670  (–2.789, 4.329)
Resection speed [g/min] 0.62 (±0.40) 0.38 (±0.25) 0.000 (0.139, 0.341)
Indwelling catheter [day] 1.77 (±1.02) 1.79 (±1.78) 0.942 (–0.430, 0.463)
Hospital stay [day] 4.91 (±3.56) 4.35 (±3.14) 0.330 (–0.564, 1.671)
Table II. Patient-related and operation characteristics of both groups
TURP – transurethral resection of prostate, TURIS – transurethral resection in saline of prostate, SD – standard deviation
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coagulation effect after monopolar cutting (216.00
±42.24 μm) [5].
The deeper coagulation capacity of bipolar
devices may be attributed to the different
mechanism of cutting and a higher baseline power
setting. Conventional monopolar devices remove
tissue by direct heating, whereas the majority of
heat is dissipated into steam and little is conducted
to coagulate tissue [8]. A power setting of 175 W is
used for cutting and 75 W for coagulation. Tissue
cutting in bipolar devices depends on the plasma
effect. High frequency energy runs from the active
pole through the conductive fluid (NaCl 0.9%) to
the return pole. Energetic species of the charged
ions cause breakage of organic carbon-carbon and
carbon-nitrogen bonds [9, 10]. Furthermore, the
plasma effect can effectively coagulate oozing
vessels at the surface of the resected tissue [11].
A higher power setting of respectively 270 W and
75 W is used. 
The results of experimental research open up
possibilities in the clinical setting. If intra-operative
blood loss is reduced, the operation field becomes
“clearer”. This allows the coagulation mode to be
used more accurately to seal all bleeding points.
However, experimental advantages are not always
clearly translated into clinical results. Table III lists
the haemoglobin changes from patients in
randomized controlled trials comparing con  -
ventional monopolar and bipolar technology [3, 9,
12-14]. Only Ho et al. reported a statistically
significantly lower blood loss using Olympus TURIS
[13]. In all other investigations, there were no
statistically significant differences between both
technologies.
Clot retention is another annoying complication
resulting from peri- and postoperative bleeding. It
may lead to longer catheterization times and
sometimes even to a need for reinterventions.
Table IV lists the number of clot retentions in all
published randomized controlled trials [9, 12-19].
Only Ruthann et al. reported a statistically
significant difference in favour of bipolar technology
[19]. A meta-analysis by Mamoulakis et al. showed
that one needs to treat 20 patients with bipolar
instead of monopolar resection to avoid one
incident of clot retention [4]. 
In the present study we examined the
haemostatic capacity of both monopolar and bipolar
technology in patients on oral anticoagulation
therapy. Antivitamins K and antiplatelets are impor  -
tant medications for patients at risk for arterial or
venous thromboembolism. Continuing intake of
these medications increases the risk of excessive
and prolonged bleeding in the perio  perative period.
Therefore, most surgeons prefer to discontinue oral
anticoagulants. This is not without risk. Bell et al.
reported a tendency for hyper  coagulation after
transurethral resection of the prostate [20]. Six h
after surgical intervention, there is a significant rise
of the thrombin/thromboplastin complex and
a decrease of thromboplastins. This complication
Study Comparing N/N Hb/Hb Value of p
Singh et al. [10] TURP vs. VISTA 30/30 –1.2/–1.2 0.91
Iori et al. [13] TURP vs. Gyrus 26/27 –1.8/–1.2 0.72
Autorino et al. [3] TURP vs. Gyrus 35/35 –1.0/–0.8 0.09
Ho et al. [14] TURP vs. TURIS 52/48 –1.8/–1.2 0.00
Michielsen et al. [15] TURP vs. TURIS 120/118 –1.3/–1.4 0.29
Table III. Changes in haemoglobin in randomized controlled trials
Hb – haemoglobin
Study Comparing N/N Clot retention/Clot retention Value of p
Singh et al. [10] TURP vs. VISTA 30/30 0/0 1.000
Yang et al. [16] TURP vs. Gyrus 59/58 7/9 0.601
Seckiner et al. [17]  TURP vs. Gyrus 24/24 0/2 0.489
Patankar et al. [18] TURP vs. Gyrus 51/52 2/0 0.243
De Sio et al. [19] TURP vs. Gyrus 35/35 4/2 0.673
Erturhan et al. [20] TURP vs. Gyrus 120/120 17/2 0.000
Iori et al. [13] TURP vs. Gyrus 26/27 5/1 0.100
Ho et al. [14] TURP vs. TURIS 52/48 2/3 0.669
Michielsen et al. [15] TURP vs. TURIS 120/118 6/4 0.749
Table IV. Clot retention in randomized controlled trials
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is responsible for the high incidences of venous
thrombosis (6.8-10%) and pulmonary embolism
after TURP (0.2-2.2%) [21, 22].
The guidelines on anticoagulants and TURP that
we have used for years are certainly disputable. We
routinely observe an appropriate wash-out period.
Patients on antivitamin K stop the intake five days
before endoscopic surgery. Replacement therapy by
low molecular weight heparins in a therapeutic
dose is administered until the day of the operation.
After surgery, intake of antivitamin K is restarted
as soon as possible. Patients on antiplatelets
interrupt this treatment one week before the
surgery. Although it is not sustained by data in the
literature, we substitute the antiplatelets with
subcutaneously administered LMWH. We restart
the oral prevention as soon as possible. 
There is no uniform management strategy
concerning anticoagulants and transurethral
prostate resections. Do we really have to stop oral
anticoagulation therapy? Parr et al. reported the
outcome of 14 patients who had continued their
oral anticoagulants throughout transurethral
resection of the prostate or bladder [23]. Blood
transfusion was needed in 4 patients (28%). A drop
of more than 2 g/dl was observed in 3 patients
(21%). Furthermore, replacement therapy by
heparins did not lead to more blood loss. Tscholl 
et al. examined 23 patients with or without
continuous administration of intravenous heparin
throughout the perioperative period [24]. In both
groups, the mean blood loss was similar. The use
of LMWH is supposed to be safer because platelet
aggregation and vascular permeability decrease to
a lesser extent than with intravenously injected
heparin [25]. However, decreased bleeding rates
after prevention with LMWH are not consistently
reported in clinical trials [26].
The possible benefit of perioperative anticoa  -
gulation must be balanced against the increased
risk of postoperative bleeding. It makes the risk of
major bleeding in the first 48 postoperative h
increase by 0-4% for major and invasive procedures
[27]. The risk of permanent disability or death after
major bleeding is 1% to 6% [27]. Permanent
disability or death after arterial thromboembolism
is common (70-75%) [27]. Venous thrombo  -
embolism is less risky but can cause permanent
disability and death in 4% to 10% of cases [27]. In
this analysis, early restart of anticoagulation therapy
led to clot retention in 14.2% of the patients. Eleven
patients were re-hospitalized.
In this matter, the choice of the endoscopic
instrument and technique is an important factor.
Each technology is conceived to reach two
important goals: to limit perioperative blood loss
and to allow the restart of oral anticoagulants as
soon as possible, preferably the day after surgery.
In a clear operation field the coagulation mode can
be used accurately to seal all bleeding points.
A point of comparison of paramount importance
between the conventional and the newer minimally
invasive techniques for TURP should be their safety
profile for bleeding incidents. Hoffman et al.
compared 1898 patients treated by TURP or laser
therapy in a large-scale meta-analysis [28]. Analysis
of symptom improvement and urine flow slightly
favoured conventional TURP . Laser therapy was
superior regarding blood loss, clot retention and
hospitalisation time. Ruszat et al. reported the
excellent haemostatic properties of photoselective
vaporization of the prostate in patients on ongoing
oral anticoagulants [29].
We did not observe a substantial advantage with
the use of bipolar technology with regard to the
occurrence of bleeding complications. We did not
note statistically significant differences in
haemoglobin changes, the number of incidents with
clot retention or the need for blood transfusions
between the monopolar and bipolar TUR systems.  
This study has some shortcomings. Whether the
short-term change in haemoglobin is a valid
parameter of blood loss is debatable. Therefore we
aimed for a standardised scheme of intravenous
fluid therapy. The assistance of a HemoCue
photometer would be more appropriate, but also
in all reported trials (Table III) this was not the case
[30]. The decision to perform a blood transfusion is
sometimes subjective. It is not only based on
a measured haemoglobin level below 8 mg/dl, but
also on the cardiovascular status of the patient.
In conclusion, bipolar transurethral resection of
the prostate claims the "gold standard" position of
conventional monopolar technology for the surgical
treatment of benign prostatic hyperplasia. This new
technology has a proven low peri- and post  -
operative complication rate and a good clinical
outcome. Experimental studies suggest that bipolar
resection provides better haemostasis and deeper
coagulation depth. However, these advantages in
experimental research are not always translated
into clinical practice. A review of randomized
controlled trials failed to demonstrate a reduction
of the preoperative and postoperative blood loss in
patients treated by bipolar technology. Even in
a study group of patients on oral anticoagulation
therapy, bipolar technology does not seem to be
superior. Whatever the technology used, patients
on oral anticoagulants suffer more incidents of clot
retention, which sometimes results in re-
hospitalisation.
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